vs. Actelion Pharmaceuticals
Payout Range
Varies
Deadline
8/3/2026
Time Left
88 days
The Tracleer / Bosentan settlement resolves a federal antitrust class action alleging that Actelion Pharmaceuticals unlawfully delayed generic bosentan from entering the U.S. market, causing third-party payors to overpay for brand-name Tracleer and generic bosentan.
Third-Party Payors only, including health plans, HMOs, insurers, self-insured employer plans, and union funds.
This settlement has the following claim path.
Payments will be distributed pro rata based on the amount each TPP paid for Tracleer and bosentan during the class period.
This settlement accepts online and mail claim submissions. Pick whichever is easier.
Print, fill out, and mail to the address below. Useful if you can't find your Unique ID / PIN for online filing.
ClaimHawk is an independent service. Review the official settlement site for legally binding terms.